Fujian Provincial Key Laboratory of Neurodegenerative Disease and Aging Research, College of Medicine, Xiamen University, Xiamen, Fujian 361005, People's Republic of China.
Mol Neurodegener. 2012 Jun 18;7:30. doi: 10.1186/1750-1326-7-30.
β-site APP cleaving enzyme 1 (BACE1) cleaves β-amyloid precursor protein (APP) to initiate the production of β-amyloid (Aβ), the prime culprit in Alzheimer's disease (AD). Dysregulation of the intracellular trafficking of BACE1 may affect Aβ generation, contributing to AD pathology. In this study, we investigated whether BACE1 trafficking and BACE1-mediated APP processing/Aβ generation are affected by sorting nexin 12 (SNX12), a member of the sorting nexin (SNX) family that is involved in protein trafficking regulation.
Herein, we find that SNX12 is widely expressed in brain tissues and is mainly localized in the early endosomes. Overexpression of SNX12 does not affect the steady-state levels of APP, BACE1 or γ-secretase components, but dramatically reduces the levels of Aβ, soluble APPβ and APP β-carboxyl terminal fragments. Downregulation of SNX12 has the opposite effects. Modulation of SNX12 levels does not affect γ-secretase activity or in vitro β-secretase activity. Further studies reveal that SNX12 interacts with BACE1 and downregulation of SNX12 accelerates BACE1 endocytosis and decreases steady-state level of cell surface BACE1. Finally, we find that the SNX12 protein level is dramatically decreased in the brain of AD patients as compared to that of controls.
This study demonstrates that SNX12 can regulate the endocytosis of BACE1 through their interaction, thereby affecting β-processing of APP for Aβ production. The reduced level of SNX12 in AD brains suggests that an alteration of SNX12 may contribute to AD pathology. Therefore, inhibition of BACE1-mediated β-processing of APP by regulating SNX12 might serve as an alternative strategy in developing an AD intervention.
β-位点 APP 裂解酶 1(BACE1)裂解β-淀粉样前体蛋白(APP)以启动β-淀粉样肽(Aβ)的产生,Aβ 是阿尔茨海默病(AD)的主要罪魁祸首。BACE1 的细胞内运输失调可能会影响 Aβ 的产生,从而导致 AD 病理学。在这项研究中,我们研究了分选连接蛋白 12(SNX12)是否会影响 BACE1 的运输以及 BACE1 介导的 APP 加工/Aβ 的产生,SNX12 是参与蛋白运输调节的分选连接蛋白(SNX)家族的成员。
在此,我们发现 SNX12 在脑组织中广泛表达,主要定位于早期内体。SNX12 的过表达不会影响 APP、BACE1 或 γ-分泌酶成分的稳态水平,但会显著降低 Aβ、可溶性 APPβ 和 APPβ-羧基末端片段的水平。SNX12 的下调则有相反的效果。调节 SNX12 的水平不会影响 γ-分泌酶的活性或体外β-分泌酶的活性。进一步的研究表明,SNX12 与 BACE1 相互作用,下调 SNX12 可加速 BACE1 的内吞作用,并降低细胞表面 BACE1 的稳态水平。最后,我们发现与对照组相比,AD 患者脑中的 SNX12 蛋白水平显著降低。
这项研究表明,SNX12 可以通过相互作用调节 BACE1 的内吞作用,从而影响 APP 的β-加工以产生 Aβ。AD 脑中 SNX12 水平的降低表明,SNX12 的改变可能导致 AD 病理学。因此,通过调节 SNX12 抑制 BACE1 介导的 APP 的β-加工可能成为开发 AD 干预策略的另一种选择。